Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
about
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injuryChemokines and the pathophysiology of neuropathic painCXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systemsChemokine-ligands/receptors: multiplayers in traumatic spinal cord injuryOpioid-induced central immune signaling: implications for opioid analgesiaMorphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptorsOpioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesiaEffects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismDisruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDSThe CC chemokine receptor 5 regulates olfactory and social recognition in mice.HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Opioids: Modulators of angiogenesis in wound healing and cancer.Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic painInteractions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Protein kinase Czeta mediates micro-opioid receptor-induced cross-desensitization of chemokine receptor CCR5.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.The cannabinoid system and immune modulation.Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells.Localized CCR2 Activation in the Bone Marrow Niche Mobilizes Monocytes by Desensitizing CXCR4.Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemiaOpiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation.The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.Intrathecal rapamycin attenuates morphine-induced analgesic tolerance and hyperalgesia in rats with neuropathic pain.Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment.The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.Viewing chemokines as a third major system of communication in the brain.Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptorThe cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.
P2860
Q24297948-819EE4FA-1B40-4F2F-A273-0C5227243B32Q24634101-88A528FC-8E64-430A-B07F-8DA0459FCC0EQ24683873-28ABA2C1-3D45-492E-9E30-D4EA6928D1BDQ26992010-D0BC3096-DB84-49F1-8861-5984A95F3A64Q27000469-8A06EF55-7DE1-422E-AF0B-8E18D541B0C8Q27021477-A438AEF1-B0EA-485C-9A61-2B27621E2618Q28570764-4E84689F-2127-487D-AB99-5FCE85CD0FE3Q28572100-7E4C4178-F1F6-4FF8-B849-30C0987B5A71Q28576512-E332C5BA-8CA3-420C-926C-E34164E066F0Q28660034-035D6776-FD3A-47D7-B25D-6F96453B5C11Q28750204-F1D18FF6-5483-467B-8101-14B03835EC9AQ30460369-060DCF17-023E-460E-B08B-A3972B4A76FCQ33647438-31433EC0-1587-4D7D-AAD3-E012D811778FQ33649031-C4D21974-474D-4CDF-A759-305AE466CF8CQ33842214-8D1D2DAD-6DB6-478E-B6B2-256DBB9F3E1FQ34020583-68C311FB-FDFC-4776-964F-654669EF0169Q34511063-BC794D7C-4012-4FCE-84AE-257AD9B751A3Q35007339-B6B39783-BFDF-4B2B-9EF0-40B2443EBFB8Q35063329-EBCA93A2-FF3D-41DD-A33A-45C01B011B74Q35122783-6CA583EE-4626-47AF-8AC1-9D3C90D08E81Q35213813-D59E0FBD-46BE-4B43-B4DB-A962046652FAQ35216669-E4F5D84D-08AE-4D27-BC90-DD23AAEC564CQ35234755-6A4BFEEE-0457-44DE-BDD4-FDEDB8253B35Q35647599-8918EBEB-8E50-45A7-A4EB-303FB9F39232Q35749650-A8729CC0-22C1-4CAE-81AF-F810BD3026C8Q35763921-7D29F14B-AA50-46D9-B6AF-36473976B5D2Q35782664-51ED7757-F07E-47C2-A17D-E5FCD22BB606Q35966430-A7E511B8-455A-4C28-86B7-98827A567B54Q36016302-32091A44-CA9B-4745-83C2-6E1C2D77FA15Q36153919-71AA415C-3B5E-497A-8C34-452E6BD5FD10Q36222441-B99A32C4-33B1-4C84-88BE-1DC9ECAEC56EQ36440374-CADC3C7B-7DE5-444F-8312-D3A714A81C8EQ36572543-5A1FB267-265C-44D8-83F8-3878C82C8264Q36681040-B8C291A6-7382-42CE-AB55-756F609DFF7CQ36686688-F4B62A92-C4DA-4DFF-BAE1-7344E9A26360Q36763295-93BD3084-EC75-49BE-99F1-0911DB9E8E82Q36839084-D1B0078B-51E1-45AC-9175-132FFB6DE6FDQ37000127-743393C3-21B8-48F2-B2AE-38485EA73D3FQ37180660-A9FC54D4-C9A9-4A12-8BE0-CD7667B82DAFQ37227396-C13FCF38-B33B-4696-A5C7-B9E02070428D
P2860
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Heterologous desensitization o ...... hances the perception of pain.
@ast
Heterologous desensitization o ...... hances the perception of pain.
@en
Heterologous desensitization o ...... hances the perception of pain.
@nl
type
label
Heterologous desensitization o ...... hances the perception of pain.
@ast
Heterologous desensitization o ...... hances the perception of pain.
@en
Heterologous desensitization o ...... hances the perception of pain.
@nl
prefLabel
Heterologous desensitization o ...... hances the perception of pain.
@ast
Heterologous desensitization o ...... hances the perception of pain.
@en
Heterologous desensitization o ...... hances the perception of pain.
@nl
P2093
P2860
P356
P1476
Heterologous desensitization o ...... hances the perception of pain.
@en
P2093
Imre Szabo
Joost J Oppenheim
Martin W Adler
Thomas J Rogers
Xiao-Hong Chen
P2860
P304
10276-10281
P356
10.1073/PNAS.102327699
P407
P50
P577
2002-07-18T00:00:00Z